Can multi-antigen Borrelia IgM reflect recent immune stimulation without proving active infection?

Borrelia serology reflects immune recognition and must be interpreted in the clinical setting, particularly in an older adult in whom nonspecific symptoms may have several competing explanations.

Interpretation of multi-antigen IgM

• Borrelia-specific IgM reactivity to multiple antigens can be consistent with a recent antigen-driven response. In typical early Lyme disease, IgM emerges about 2–4 weeks after erythema migrans and peaks at roughly 6–8 weeks, before IgG becomes more prominent.
• This pattern is therefore most informative when it coincides with a compatible acute syndrome, plausible tick exposure, and validated two-tier test interpretation. It does not independently demonstrate that immune stimulation is recent, renewed, or due to current infection.

Persistence and nonspecific reactivity

• Both Borrelia-specific IgM and IgG can remain detectable for years or decades after infection has been eradicated or successfully treated. In one long-term observation 10–20 years after Lyme disease, IgM remained detectable in 10% of people previously treated for early disease and 15% of those with prior Lyme arthritis.
• Multiple reactive IgM antigens do not eliminate alternative explanations. Cross-reactivity at commonly assessed antigens and nonspecific/polyreactive B-cell responses can produce isolated or multi-band IgM patterns. Experimental murine work also suggests Borrelia components can induce broad B-cell/IgM activation, although this does not establish diagnostic meaning in humans.

Clinical implications

• Antibodies document prior or current immune recognition, not infection activity. Serology should not alone be treated as evidence of treatment failure or an indication for antibiotics.
• Active disease requires compatible symptoms and exposure history. Isolated IgM without IgG, particularly when symptoms have lasted >30 days, is especially prone to misleading interpretation.
• For suspected central nervous system neuroborreliosis, serum testing is insufficient: CSF inflammation/pleocytosis plus a validated CSF:serum Borrelia antibody index are important supportive findings.

Bottom line

• Multi-antigen Borrelia IgM may fit recent immune stimulation, but persistent antibodies and nonspecific reactivity mean antibody findings alone cannot establish active or recurrent Borrelia infection.